Portola Pharmaceuticals

Portola Pharmaceuticals

Verified
Therapeutics for acute and chronic cardiovascular, and autoimmune and inflammatory diseases

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
R&D budget234m168m188m111m---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
$21mSeries A
$46mSeries B
$70mSeries C
$60.1mSeries C
Not yet verified
$60.1mSeries C
$89mSeries D
N/A$9mEarly VC
N/AN/AIPO
*
N/A$100mPost IPO Equity
Not yet verified
*
N/A$150mPost IPO Equity
Not yet verified
*
N/A$349mPost IPO Equity
Not yet verified
$125mPost IPO Debt
Not yet verified
*
N/A$259mPost IPO Equity
Not yet verified
*
$1.4b
Valuation: $1.4b
Acquisition
Total Funding$295m

Recent News about Portola Pharmaceuticals

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.